Early research (Phase 1)Study completedNCT01875926What this trial is testingALX-0171 Phase I Pharmacokinetic Study in Healthy Male VolunteersWho this might be right forHealthyRSV Infection Ablynx, a Sanofi company 44
Not applicableUnknownNCT04531735What this trial is testingRespiratory Syncytial Virus Infection May be More Dangerous in NeonateWho this might be right forRSV InfectionCovid19 Dr. Behcet Uz Children's Hospital 28
Not applicableLooking for participantsNCT06161285What this trial is testingAssociation of Dysbiosis and Immune Response in Bronchiolitis in Under 12 Months -Old InfantsWho this might be right forBronchiolitis Assistance Publique - Hôpitaux de Paris 120
Testing effectiveness (Phase 2)Study completedNCT00192478What this trial is testingOpen-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524Who this might be right forRespiratory Syncytial Virus Infections MedImmune LLC 217
Testing effectiveness (Phase 2)Ended earlyNCT06784973What this trial is testingStudy of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) InfectionWho this might be right forRSV Infection Gilead Sciences 4
Not applicableStudy completedNCT00263900What this trial is testingTGV:Use of the Quick Diagnostic Test of the Influenza and the Infection With RSV by the Paediatric Emergency UnitWho this might be right forInfluenzaRespiratory Syncytial Viruses University Hospital, Rouen 377
Large-scale testing (Phase 3)Study completedNCT06060457What this trial is testingEvaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of AgeWho this might be right forRespiratory Syncytial Virus ModernaTX, Inc. 1,900
Large-scale testing (Phase 3)Looking for participantsNCT06955728What this trial is testingA Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo.Who this might be right forRSV InfectionsRSV ImmunisationPreterm Labour University of Witwatersrand, South Africa 13,000
Testing effectiveness (Phase 2)Study completedNCT05687279What this trial is testingStudy on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)Who this might be right forRespiratory Syncytial Virus Infection Sanofi Pasteur, a Sanofi Company 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT07208461What this trial is testingEvaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and OlderWho this might be right forRespiratory Syncytial Virus Infection Prevention Guangzhou Patronus Biotech Co., Ltd. 700
Early research (Phase 1)Study completedNCT02952339What this trial is testingEvaluating the Infectivity, Safety, and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants and Children 6 to 24 Months of AgeWho this might be right forRespiratory Syncytial Virus Infections National Institute of Allergy and Infectious Diseases (NIAID) 33
Not applicableStudy completedNCT06746051What this trial is testingInvestigate How Respiratory Syncytial Virus (RSV) Infection Develops and Changes Over Time in Pediatric ParticipantsWho this might be right forRSV Infections Shionogi 100
Early research (Phase 1)Study completedNCT02231671What this trial is testingA Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176Who this might be right forRespiratory Syncytial Virus Infections Alios Biopharma Inc. 12
Not applicableStudy completedNCT05765396What this trial is testingSARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies (Level42)Who this might be right forCOVID-19SARS-CoV-2 VirusCOVID-19 Pneumonia+5 more The Geneva Foundation 300
Not applicableStudy completedNCT00246480What this trial is testingRSV Disease in the ElderlyWho this might be right forRespiratory Infections, AcuteRespiratory Syncytial Virus National Institute of Allergy and Infectious Diseases (NIAID) 1,401
Large-scale testing (Phase 3)Ended earlyNCT06079320What this trial is testingLearn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) InfectionWho this might be right forRespiratory Syncytial Virus Infection Pfizer 16
Not applicableStudy completedNCT03062917What this trial is testingNasal and Bronchial Absorption Sampling in RSV BronchiolitisWho this might be right forBronchiolitisBronchiolitis, ViralRSV Infection+1 more Imperial College Healthcare NHS Trust 152
Early research (Phase 1)UnknownNCT03436225What this trial is testingSteroid Therapy in Acute Bronchiolitis A New Old Line of Therapy.Who this might be right forBronchiolitis; Respiratory Syncytial Virus Assiut University 80
Not applicableStudy completedNCT01224691What this trial is testingTGF-(Beta) and Susceptibility to RSVWho this might be right forAsthma National Institute of Environmental Health Sciences (NIEHS) 113
Testing effectiveness (Phase 2)Study completedNCT02309320What this trial is testingA Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171Who this might be right forRespiratory Syncytial Virus Infection Ablynx, a Sanofi company 53